Emerg Infect DisEIDEmerging Infectious Diseases1080-60401080-6059Centers for Disease Control and Prevention18598636260033807-133910.3201/eid1407.071339DispatchSudden Onset of Pseudotuberculosis in Humans, France, 2004–05Sudden Onset of Pseudotuberculosis in Humans, France, 2004–05Pseudotuberculosis in Humans, France, 2004–05VincentPascal*1LeclercqAlexandre§1MartinLiliane§Yersinia Surveillance Network§DuezJean-MarieSimonetMichel*2CarnielElisabeth§2Institut National de la Santé et de la Recherche Médicale (INSERM), Lille, FranceUniversité Lille 2, LilleInstitut Pasteur de Lille, LilleInstitut Pasteur, Paris, FranceCentre Hospitalier du Bocage, Dijon, FranceThese authors contributed equally to this article.These authors contributed equally to the supervision of this work.Address for correspondence: Pascal Vincent, Service de Bactériologie-Hygiène, Centre de Biologie Pathologie/Centre Hospitalier Régional Universitaire de Lille, bd du Pr J. Leclercq, F-59 037 Lille CEDEX, France; email: p-vincent@chru-lille.fr7200814711191122

Cases of Yersinia pseudotuberculosis infection increased in France during the winter of 2004–05 in the absence of epidemiologic links between patients or strains. This increase represents transient amplification of a pathogen endemic to the area and may be related to increased prevalence of the pathogen in rodent reservoirs.

Keywords: Yersinia pseudotuberculosisdisease outbreaksFrancedispatch

Yersinia pseudotuberculosis is an enterobacterial pathogen able to grow at low temperatures. It is widespread in the environment (e.g., water, plants), which is the source of contamination for mammals (especially rodents and their predators) and birds (1,2). Although most cases of human infection are sporadic, outbreaks have occurred in Japan (3,4), Russia (5,6), and Finland (7,8), mainly associated with unchlorinated drinking water or contaminated vegetables. In France, similar increases in case numbers had not been noted until the winter of 2004–05.

The Study

In early January 2005, the French Yersinia National Reference Laboratory (YNRL) received 3 Y. pseudotuberculosis strains isolated by the same laboratory in Dijon over a 1-week period: 2 from fecal samples of 2 children attending the same daycare center and 1 from the blood of a 65-year-old woman. During the same month, 8 additional strains were isolated from persons in other parts of the country by the Yersinia Surveillance Network (based on voluntary participation of 88 hospital-based and private-sector medical laboratories throughout France).

In view of this unusually high number of Y. pseudotuberculosis isolations over a short period, the YNRL alerted France’s national disease surveillance network, the Institut de Veille Sanitaire, which thereafter performed an epidemiologic investigation. In early February, a request was mailed to all member laboratories in the Yersinia Surveillance Network and all 95 microbiology laboratories in university medical centers, asking them to report any recent cases of Y. pseudotuberculosis infection. A reminder letter was mailed to all laboratories that had not replied within 1 month of the initial communication. Moreover, from February through April 2005, a total of 76 general medical center laboratories were contacted by telephone and asked to provide the YNRL with any relevant information and/or isolates. Overall, 27 cases of culture-confirmed Y. pseudotuberculosis infections were spontaneously reported or actively retrieved (Table 1).

Relevant characteristics of 27 patients with <italic>Yersinia pseudotuberculosis</italic> infection, France, winter 2004–05*
Age, ySexRisk factorsMain clinical signs/symptomsSite of organism isolationO serotypeIllness outcome
0.8MNoneDiarrheaFecesIRecovery
1MNoneDiarrheaFecesIIIRecovery
2FNoneDiarrheaFecesIRecovery
6MNoneDiarrheaFecesIRecovery
9FNoneDiarrheaFecesIRecovery
17MMultiple injuries (motorcycle accident)Postsurgical infection†BloodIRecovery
36FHIV infectionDiarrhea, mesenteric adenitisFecesIRecovery
44FBone marrow transplantationFeverBloodIDeath
51FSickle cell anemia, cirrhosisDiarrhea, esophageal variceal bleedingBloodIDeath
59MCirrhosisFever, esophageal variceal bleedingBloodIRecovery
61MTherapeutic aplasia (colorectal cancer)Fever, abdominal painBloodIDeath
64MAbdominal aortic aneurysmAbdominal painArtery biopsyIRecovery
65FMyelomaFever, septic shockBloodIDeath
70MCirrhosisFeverBloodIRecovery
71MUnknownAbdominal painBloodNA strainRecovery
71MDiabetes, steroid receipt (for retroperitoneal fibrosis)Fever, diabetes decompensationBloodIRecovery
72MKidney transplantationFeverBloodIRecovery
74MDiabetesFever, abdominal painBloodNSRecovery
75MViral hepatitis C infectionFeverBloodIRecovery
76MCirrhosisFeverBloodNSRecovery
78MCalcific aortic stenosisFever, acute heart failureBloodIRecovery
78MDiabetesFever, septic shockBlood and artery biopsyIDeath
79MMetastatic colorectal cancerFever, respiratory distress syndromeBloodIDeath
80MCerebrovascular accidentFever, cardiogenic shockBloodNA strainRecovery
81FCirrhosisFeverBloodIRecovery
82MDiabetesFever, septic shockBloodNA strainDeath
83MDiabetesFeverBloodIRecovery

*NA, nonagglutinable; NS, not sent to Yersinia National Reference Laboratory.
 †This patient’s signs/symptoms began after hospitalization; all other patients’ signs/symptoms began before hospitalization.

Case reports of Y. pseudotuberculosis infection peaked in January 2005. A food-exposure analysis for the first 10 patients did not identify a potential common food source, so a food survey was not performed for subsequent cases. The pseudotuberculosis cases occurred in 19 different counties throughout France, not necessarily the most populated ones (Figure 1). Data on lifestyle and living conditions were obtained for all but 7 patients, of whom 3 had died and 4 (including 2 children) were lost to follow-up. Of the 22 adults, 13 lived in small towns (<5,000 inhabitants) and 5 lived in rural villages (<500 inhabitants). All but 4 lived in houses, as opposed to apartments. Of the 17 adults whose lifestyle was investigated in detail, 14 had a dog, hunted, gardened, and/or grew their own vegetables. In contrast, all 5 children lived in urban areas (>50,000 inhabitants), compared with only 3 of the 22 adults; 4 of the children lived in apartments.

Map of France, showing spatial distribution of Yersinia pseudotuberculosis infections during the winter of 2004–05. Black circles, patients' residences; open circles, cities with medical laboratories that stated that they had not isolated any Y. pseudotuberculosis from clinical specimens.

Of the 27 strains isolated, 25 were sent to the YNRL for characterization. All but 4 strains belonged to serotype I, the most common serotype in France. Pulsed-field gel electrophoresis after SpeI digestion of genomic DNA showed that (with the exception of the isolates from the 2 children attending the same daycare center) the DNA fingerprints of the 16 other isolates sent to the YNRL during the peak period were all distinct, even when the strains were isolated from the same county (data not shown).

Conclusions

This episode of increased case numbers differs from episodes reported in the literature by the nationwide distribution of cases, the absence of a locally defined cluster, the genetic diversity of the isolates, the predominance of rural residence for patients, and the dominant clinical presentation of septicemia (38). Because the cases were not related to the consumption of a food product sold nationally (e.g., by a supermarket chain), the unknown origin of this phenomenon raises the question of an emerging risk in a new epidemiologic situation.

Of the 27 patients, 19 lived in a strip of land that stretches from northern France to the Atlantic coast and corresponds to the flyways of small migratory birds. Hence, the avian introduction of strains into the country would have been a possible scenario, as has already been suspected for an epizootic of pseudotuberculosis in an American wildlife park (9). Indeed, during the winter of 2004–05, France witnessed a large and unexpected invasion of Bohemian waxwings (Bombycilla garrulus) (10), a species known to migrate from circumpolar areas where pseudotuberculosis is endemic. At that same time, 3 pseudotuberculosis outbreaks were reported in Siberia (11). However, the genetic diversity of the strains isolated from the patients in France and the absence of PCR amplification of the superantigen-encoding gene ypm gene (12) (which is highly prevalent in Far Eastern strains [1]) do not support bird-borne arrival in France of a Y. pseudotuberculosis clone from Russia or the Far East.

These cases occurred in areas where other human cases of Y. pseudotuberculosis septicemia had been diagnosed (albeit at a much lower rate) in the past 16 years (Figure 2). Exacerbation of a preexisting epidemiologic situation is quite likely. Most previous cases of Y. pseudotuberculosis septicemia also concerned inhabitants of low-altitude plains (Figure 2), mainly in rural areas with extensive agriculture zones, which provide favorable habitats for small mammals. Cases were frequently (27.1%) reported in 5 central-western counties of France, where just 4.6% of the population live and incidence of Francisella tularensis infection (tularemia) is high (27.3%) (www.invs.sante.fr/surveillance/tularemie/donnees.htm). Moreover, 40 cases of tularemia (with incidence peaks in summer and autumn) were reported to the national surveillance system in 2004 (notification of the disease has been obligatory since 2002), whereas only 8 to 19 cases per year had been reported over the preceding and following periods. Like Y. pseudotuberculosis, F. tularensis is known to have a rodent reservoir. Hence, the spatial and temporal correlations between human tularemia and pseudotuberculosis in France over recent years suggest the sudden expansion of a common reservoir in 2004.

County distribution, France, of Yersinia pseudotuberculosis isolated from human blood and reported to the Yersinia National Reference Laboratory over the 16 years preceding the winter of 2004–05. The number of isolates is represented by proportionally sized circles arbitrarily located at the center of the counties.

Our analysis of the temporal distribution of human Y. pseudotuberculosis septicemia cases over the past 16 years showed a peak every 5 years (Table 2). This finding is reminiscent of human hantavirus infections, which have been linked to cyclical oscillations in the vole population (the virus reservoir). Taken as a whole, these data suggest that a rodent reservoir, mainly in rural areas, could have suddenly increased in the spring of 2004, thus increasing the risk for human transmission of Y. pseudotuberculosis and F. tularensis over the following months.

Temporal distribution of receipt of<italic>Yersinia pseudotuberculosis</italic> blood isolates, France
PeriodMonthly isolates*
Annual isolates
SepOctNovDecJanFebMarAprMayJunJulAug
1988–890000112100106
1989–900010121011007
1990–910100110400007
1991–920001011010004
1992–930000110100003
1993–940000003020005
1994–950000131200018
1995–960000103002017
1996–970000010000001
1997–980000200000013
1998–990000000101002
1999–000001021002118
2000–010000100102004
2001–020011000010003
2002–030000011000002
2003–040000014102008
2004–05†00004455000018
2005–06
0
0
0
0
0
2
2
0
0
0
0
0
4
1988–2006‡01 
(0.06)§2 
(0.12)3 
(0.18)9 
(0.53)16 (0.94)19 (1.12)11 (0.65)5 
(0.29)10 (0.59)2 
(0.12)4 
(0.24)82
(4.82)

*Received by the French Yersinia National Reference Laboratory since September 1988. To encompass the whole cold season, isolates are presented in 12-month periods from September to August.
†Period of increased number of cases.
‡Excludes 2004–05.
§Numbers in parentheses are mean monthly value over the 17 years in which case numbers were not increased.

Rodent populations tend to increase with ongoing changes in agricultural practices, e.g., removal of farmland hedges (which provide shelter for the rodents’ predators) and reduction in pesticide use. Hence, the dynamics of the wild rodent population and reduction in pesticide use may represent a useful predictive marker for the occurrence of new outbreaks. The surveillance and control of the small mammal population might help limit the incidence of pseudotuberculosis and other wild rodent–borne diseases of humans in France.

Suggested citation for this article: Vincent P, Leclercq A, Martin L, Yersinia Surveillance Network, Duez J-M, Simonet M, et al. Sudden onset of pseudotuberculosis in humans, France, 2004–05. Emerg Infect Dis [serial on the Internet]. 2008 Jul [date cited]. Available from http://www.cdc.gov/EID/content/14/7/1119.htm

Acknowledgments

We acknowledge the contributions of A. Goudeau, D. Poisson, L. Bret, R. Sanchez, H. Biessy, M. Weber, J.L. Fauchère, G. Chambreuil, P. Geslin, J.M. Seigneurin, G. Grise, J.C. Reveil, C. Auvray, and C. Recule. We also thank H. Porcheret, A. Secher, A. Marmonier, V. Sivadon, and F. Deyroys du Roure for sending the Y. pseudotuberculosis isolates to YNRL and/or for providing clinical information about patients. We also acknowledge the help of E. Espié and V. Vaillant for food exposure investigations and that of A. Mailles for obtaining national data on human tularemia.

Dr Vincent, a medical microbiologist at the Lille University Medical Center, is an associate member of the Institut National de la Santé et de la Recherche Médicale Unité 801 research group on the pathogenesis of Yersinia species. His main research interests are clinical microbiology and the epidemiology of infectious diseases.

ReferencesFukushima H, Matsuda Y, Seki R, Tsubokura M, Takeda N, Shubin FN, Geographical heterogeneity between Far Eastern and Western countries in prevalence of the virulence plasmid, the superantigen Yersinia pseudotuberculosis-derived mitogen, and the high-pathogenicity island among Yersinia pseudotuberculosis strains.J Clin Microbiol 2001;39:35417 10.1128/JCM.39.10.3541-3547.200111574570Niskanen T, Waldenstrom J, Fredriksson-Ahomaa M, Olsen B, Korkeala H virF-positive Yersinia pseudotuberculosis and Yersinia enterocolitica found in migratory birds in Sweden.Appl Environ Microbiol 2003;69:46705 10.1128/AEM.69.8.4670-4675.200312902256Inoue M, Nakashima H, Ishida T, Tsubokura M Three outbreaks of Yersinia pseudotuberculosis infection.Zentralbl Bakteriol Mikrobiol Hyg [B] 1988;186:504113142167Nakano T, Kawaguchi H, Nakao K, Maruyama T, Kamiya H, Sakurai M Two outbreaks of Yersinia pseudotuberculosis 5a infection in Japan.Scand J Infect Dis 1989;21:1759 10.3109/003655489090399662658021Somov GP, Martinevsky IL New facts about pseudotuberculosis in the USSR. On the outcome of the first conference on human pseudotuberculosis in the USSR.Contrib Microbiol Immunol 1973;2:2146Smirnova YY, Tebekin AB, Tseneva GY, Rybakova NA, Rybakov DA Epidemiological features of Yersinia infection in a territory with developed agricultural production. Epinorth 2004 [cited 2005 April 1]. Available from http://www.epinorth.org/artikler/?id=44884Jalava K, Hallanvuo S, Nakari UM, Ruutu P, Kela E, Heinasmaki T, Multiple outbreaks of Yersinia pseudotuberculosis infections in Finland.J Clin Microbiol 2004;42:278991 10.1128/JCM.42.6.2789-2791.200415184472Hallanvuo S, Nuorti P, Nakari UM, Siitonen A Molecular epidemiology of the five recent outbreaks of Yersinia pseudotuberculosis in Finland.Adv Exp Med Biol 2003;529:30912 10.1007/0-306-48416-1_5812756776Welsh RD, Ely RW, Holland RJ Epizootic of Yersinia pseudotuberculosis in a wildlife park.J Am Vet Med Assoc 1992;201:14241644638Fouarge J, Vandevondele P Synthesis on the exceptional invasion of waxwings (Bombycilla garrulus) in Europe in 2004–2005[in French] Aves.2005;42:281311Yersiniosis—Russia (Siberia) Promed. 2005 Apr 27. Available from http://www.promedmail.org, archive no: 20050427.1169.Carnoy C, Floquet S, Marceau M, Sebbane F, Haentjens-Herwegh S, Devalckenaere A, The superantigen gene ypm is located in an unstable chromosomal locus of Yersinia pseudotuberculosis.J Bacteriol 2002;184:448999 10.1128/JB.184.16.4489-4499.200212142419